Krause Kevin Michael bought ANTX
January 2, 2024 · Form 4 insider transaction
Krause Kevin Michael bought 2,583 shares of AN2 Therapeutics, Inc. at $0.42 per share, a transaction worth $1.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,583
Price
$0.42
Total value
$1.1K
InsiderKrause Kevin Michael
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after4,497
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2023.; Reflects the adjusted total which includes the purchase of 934 shares under the AN2 Employee Stock Purchase Plan on March 31, 2023.; Reflects the adjusted total which includes the purchase of 980 shares under the AN2 Employee Stock Purchase Plan on September 29, 2023.